Additional Resources

A Patient-Centered Website on the Types, Causes, Prevention and Management of Brain Bleeds, with a particular section on anticoagulants and their alternatives for atrial fibrillation patients at higher intracerebral hemorrhage risk.

HARmoNising Brain Imaging MEthodS for VaScular Contributions to Neurodegeneration (HARNESS) is a multidisciplinary group composed of neurologists, neuroradiologists, psychiatrists, neuroimaging scientists, biomedical engineers, physicists, and computer scientists. The objective of HARNESS is to disseminate and, where appropriate, standardize neuroimaging protocols for measuring the contributions of vascular disease to dementia and neurodegeneration. Many of the neuroimaging markers standardized are related to cerebral small vessel diseases (microbleeds, superficial siderosis, white matter disease,…) that directly apply to the Neuro-AFib Study's aim to predict the risk of brain bleeds, the most serious complication of long-term anticoagulant therapy.